Clinical trial
An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic…
NCT00730171 · Ironwood Pharmaceuticals, Inc., Industry · Completed
Key facts
| NCT number | NCT00730171 |
|---|---|
| Title | An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation |
| Official title | An Open-label, Long-term Safety Study of Oral Linaclotide Administered to Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation |
| Lead sponsor | Ironwood Pharmaceuticals, Inc., Industry |
| Collaborators | Forest Laboratories Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Irritable Bowel Syndrome With Constipation, Chronic Constipation |
| Intervention type | Drug |
| Interventions | Linaclotide |
| Enrollment | 1,743 |
| Start date | Sep 1, 2008 |
| Primary completion | Mar 1, 2012 |
| Completion | Mar 1, 2012 |
| First posted | Aug 8, 2008 |
| Last update posted | Feb 19, 2018 |
| Countries | United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: